Post-translational modification of MTF-1 (metal-response-element-binding transcription factor-1) was suggested to play a role in its metalloregulatory functions. In the present study, pulse labelling and two-dimensional electrophoresis-Western blotting were used to demonstrate that, although MTF-1 is highly modified in vivo, its phosphorylation level does not rapidly change in response to metals, nor does its overall modification pattern. Recombinant MTF-1 was found to serve as an in vitro substrate for casein kinase II, c-Jun N-terminal kinase and protein kinase C, but inhibition of these kinases in vivo did not significantly change the modification pattern of MTF-1. Northern blotting revealed that inhibitors of casein kinase II and c-Jun N-terminal kinase severely attenuate the metal-induced transcription of the native chromatinpackaged metallothionein-I and zinc transporter-1 genes, whereas protein kinase C inhibitors exerted gene-and cell-type-specific effects on the metal regulation and basal expression of these two genes. A chromatin immunoprecipitation assay was used to demonstrate that none of these inhibitors prevent the metal-dependent recruitment of MTF-1 to the MT-I promoter. In brief, results of the present study suggest that protein kinases may not alter the phosphorylation state of MTF-1 during the rapid-response phase to metals, nor do they regulate the metal-dependent formation of a stable MTF-1-chromatin complex. Instead, protein kinases may exert their interdependent effects on metal-induced gene expression by acting on cofactors that interact with MTF-1.
INTRODUCTION
Heavy metal homoeostasis and detoxification systems in higher eukaryotes are often regulated at the transcriptional level by metalsensing transcription factors. Metal-induced expression of MT (metallothionein), a class of metal-chelating proteins that facilitate storage and transfer of metal ions, and ZnT-1 (zinc transporter-1), a plasma membrane protein that effluxes excess zinc, are regulated by MTF-1 (MRE-binding transcription factor-1, where MRE stands for metal-response element) [1, 2] . MTF-1 is an evolutionarily conserved transcription factor that regulates gene expression in response to heavy metals, oxidative stress and hypoxia (see [3, 4] for reviews). Its target genes include, but are not limited to, MT [1] , ZnT-1 [2] and glutamate-cysteine ligase heavy chain (γ GCS hc ) genes [5] . Homozygous knockout of the mouse MTF-1 gene in cultured cells abolishes both basal and heavy-metal-induced expression of MT and ZnT-1 genes [1, 2] , whereas homozygous knockout of this gene in mice abrogates embryonic expression of the MT-I gene, significantly attenuates the expression of the ZnT-1 and γ GCS hc genes in the embryo and causes fetal death due to liver degeneration [2] [3] [4] [5] .
MTF-1 contains six Cys 2 His 2 zinc fingers and three transactivation domains [6] [7] [8] . The six zinc fingers are structurally and functionally heterogeneous [9] [10] [11] [12] [13] [14] [15] and play an essential role in the metalloregulatory functions of MTF-1 [7, 8, [13] [14] [15] . However, the molecular mechanisms by which MTF-1 activates gene transcription in response to heavy metals are not completely understood. A current model of the mechanisms of MTF-1 action suggests that direct interactions between zinc and a subset of the zinc fingers of MTF-1 reversibly modulate MTF-1 DNA-binding activity [16] [17] [18] , promote its rapid translocation into the nucleus [19, 20] and facilitate the formation of a stable MTF-1-MT-I promoter-chromatin complex [15] . The three C-terminal transactivation domains of MTF-1 then modulate MT-I gene transcription (see [3, 4] for reviews). A conserved cysteine-rich region near these transactivation domains of MTF-1 is also essential for the transactivation of gene expression by MTF-1 in response to metals [21] .
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Figure 1 Delineation of conserved consensus phosphorylation sites for various protein kinases in mouse MTF-1
Mouse MTF-1 contains six consensus PKC sites ( ), 11 consensus CKII sites ( ) and ten consensus JNK sites (*), among other protein kinase consensus sites (not shown). These consensus protein kinase sites are distributed throughout the entire peptide, including the zinc-finger domain, the transactivation (acidic, proline-rich and serine/threonine-rich) domains and the cysteine-rich region (CR). The eight-amino-acid FLAG tag (hatched flag shape) was added to the C-terminus of MTF-1 to facilitate identification of the protein.
MTF-1-chromatin complex at the MT-I promoter occurs rapidly in response to both zinc and cadmium in vivo [15] , and mutations in MTF-1 zinc fingers that block zinc-induced MT-I gene expression also abolish its induction by cadmium [15] . Furthermore, a recent report showed that cadmium activation of MTF-1-dependent in vitro transcription required Zn 7 -MT as a source of zinc [23] . Thus these two metals appear to utilize a common zincdependent mechanism to facilitate MTF-1-DNA interactions, but may employ distinct co-activators and/or signal transduction cascades to regulate gene expression. Recent studies suggest that post-translational modification of MTF-1 may also play a role in its mechanism of action [24] [25] [26] [27] . A survey of the MTF-1 peptide reveals numerous evolutionarily conserved consensus phosphorylation sites, including those for CKII (casein kinase II), PKC (protein kinase C) and JNK (c-Jun N-terminal kinase) (Figure 1 ). Inhibitors of these protein kinases have been shown to block metal induction of MT-I gene expression and the MRE-dependent activation of transiently transfected reporter genes [24] [25] [26] [27] . Effects of protein kinase inhibitors on the metal-induced expression of other MTF-1 target genes have not been reported. MTF-1 is phosphorylated in vivo [25] [26] [27] , but its role in the metalloregulatory functions of MTF-1 has not been addressed directly.
The mechanism(s) by which the inhibition of these kinases interferes with MTF-1-regulated gene expression warrants further investigation. Protein kinase inhibitors that inhibit metal-induced expression of the MT-I gene do not inhibit the in vitro DNAbinding activity or the nuclear translocation of MTF-1 [25] [26] [27] . However, neither an increase in the in vitro DNA-binding activity nor the nuclear translocation of MTF-1 ensures the formation of a stable MTF-1-chromatin complex, which is a rate-limiting step in MTF-1 activation of MT-I gene expression [15] . The effects of these kinase inhibitors on the metal-dependent formation of a stable MTF-1-chromatin complex has not been investigated. In the present study, we demonstrate the following: (i) inhibitors of PKC, CKII and JNK attenuate the metal-induced expression of the MT-I and ZnT-1 genes; (ii) inhibitors of PKC have differential effects on the transcription of the MT-I and ZnT-1 genes in different cell types; (iii) although MTF-1 can serve as an in vitro substrate for PKC, CKII and JNK, neither metal treatment nor inhibition of these kinases causes a significant change in the phosphorylation level or modification pattern of MTF-1; and (iv) protein kinase inhibitors that block metal-induced transcription of the native MT-I gene do not diminish the metal-dependent recruitment of MTF-1 to the MT-I promoter. These results suggest that signal transduction cascades may exert their effects on metalregulated gene transcription through mechanisms that are independent of changes in the modification pattern of MTF-1. Instead, these signalling events may target other cell-type-and gene-specific proteins that co-operate with MTF-1 to activate gene transcription.
EXPERIMENTAL

Cell culture
Mouse Hepa cells were maintained in Dulbecco's modified Eagle's medium with high glucose content, supplemented with 2 % (v/v) fetal bovine serum. Two stably transfected MEF (mouse embryo fibroblast) cell lines (lines 9 and 42) that express mouse MTF-1 flag , as described previously [15] , were maintained in Dulbecco's modified Eagle's medium supplemented with 10 % (v/v) fetal bovine serum and 200 µg/ml hygromycin B (Invitrogen, Carlsbad, CA, U.S.A.). These culture conditions were termed 2 and 10 % basal medium respectively. Cells were treated at 75-90 % confluency.
Northern blotting
Cells (80-90 % confluency) were pretreated for 1 h with the indicated kinase inhibitors, before a 4 h incubation in basal medium with or without ZnSO 4 (100 µM) or CdCl 2 (20 µM). Total RNA was isolated using TRIzol ® reagent (Invitrogen). Poly(A) + (polyadenylated) RNA was purified from 100-250 µg of total RNA using Oligotex mRNA mini kits (Qiagen, Valencia, CA, U.S.A.). Total RNA (2 µg) or poly(A)
+ RNA (from 20 µg of total RNA), as indicated in the legend to Figure 2 , was separated by denaturing agarose-formaldehyde gel electrophoresis, transferred and UV cross-linked to Nytran Supercharge nylon membranes (Schleicher and Schuell, Keene, NH, U.S.A.). Northern blots were prehybridized, hybridized with an MT-I or ZnT-1 cRNA probe and washed as described previously [28] . Hybrids were detected by autoradiography at − 70
• C with intensifying screens. Acridine Orange staining of rRNA or Northern blotting with a β-actin cRNA probe was used as a control to normalize for RNA amount and integrity.
Metabolic labelling and immunoprecipitation of MTF-1
Hepa cells (75 % confluent in 10 cm plates) were washed twice with PBS, three times with prewarmed phosphate-deficient medium and incubated for 3 h in 2 ml of prewarmed phosphatedeficient medium containing 2 % serum and 2 mCi of [ 32 P]P i (150 mCi/ml). The cells were then treated for 30 min with zinc (100 µM) or cadmium (10 µM), washed three times with cold PBS containing 0.1 mM Na 3 VO 4 , and scraped off the plates in 800 µl of lysis buffer (50 mM Tris, pH 7.4, 500 mM NaCl, 50 mM NaF, 1 mM EDTA, 1 mM Na 3 VO 4 , 20 mM β-glycerol phosphate, 5 mM benzamidine, 10 µg/ml leupeptin, 10 units/ml aprotinin, 1 mM PMSF and 1 % Brij 98). The scraped cells were incubated on ice for 30 min, and cell lysates were clarified by centrifugation for 10 min at 500 g at 4
• C. MTF-1 was collected by immunoprecipitation using a rabbit antiserum against recombinant mouse MTF-1 described previously [19] . The supernatants (800 µg of protein), diluted in lysis buffer containing 150 mM NaCl, were incubated overnight with Protein A-Sepharose beads (60 µl of 1:1 slurry) at 4
• C to remove the proteins that bind to the Sepharose beads non-specifically, and the beads were removed by centrifugation. The precleared supernatants were then incubated with 1 µl of anti-MTF-1 antibody or preabsorbed anti-MTF-1 antibody (as a negative control) at room temperature (23 • C) for 1 h, followed by incubation with Protein A-Sepharose beads (60 µl of 1:1 slurry) for an additional 2 h. The preabsorbed anti-MTF-1 antibody was prepared by incubating the anti-MTF-1 antibody with recombinant MTF-1 purified from Escherichia coli at 4
• C for 2 h. The beads were washed four times with lysis buffer containing 150 mM NaCl. MTF-1, eluted in 1.5 × SDS sample buffer, was then subjected to SDS/PAGE. The gel was dried and exposed to a Kodak film at − 70 • C. 
Two-dimensional electrophoresis and Western blotting
Recombinant mouse MTF-1 flag , isolated from E. coli by anti-FLAG affinity chromatography as described above, was dissolved 1:1 in urea sample buffer [9. • C for 15 min in osmotic lysis buffer (10 mM Tris, pH 7.4, 0.3 % SDS, 1 mM Na 3 VO 4 and 20 mM NaF) and incubated at 4
• C for another 1 h in this buffer containing 1 × nuclease stock [5 mM MgCl 2 , 10 mM Tris, pH 7.0, 50 µg/ml RNase A (Sigma), 100 µg/ml DNase I (Sigma) and 1 × protease inhibitors [0.2 mM 4-(2-aminoethyl)benzenesulphonyl fluoride (Calbiochem, La Jolla, CA, U.S.A.), 10 µg/ml leupeptin (Sigma), 3.6 µg/ml trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane (Sigma), 5 mM EDTA (Calbiochem) and 56 µg/ml benzamidine (Sigma)]]. Total protein content was determined using the BCA (bicinchoninic acid) protein assay (Pierce, Rockford, IL, U.S.A.) with BSA (Sigma) as a standard. An equal volume of urea sample buffer was then added to the lysate. The resulting mixture was heated at 50
• C for 1 min, spun briefly and the supernatant (150 µg of protein) was used for two-dimensional electrophoresis (Kendrick Labs). IEF (isoelectric focusing) was performed using 2 % (pH 3.5-10) ampholines (LKB-Pharmacia, Piscataway, NJ, U.S.A.). An IEF internal standard, tropomyosin (pI 5.2), was included in each sample. Recombinant MTF-1 flag isolated from E. coli was detected by Coomassie Blue staining, and the identity of the protein was confirmed by MS fingerprinting (Kendrick Labs). For these mammalian cell lysates, the SDS slab gel was transblotted on to PVDF membranes (Kendrick Labs) and MTF-1 flag was detected using an anti-FLAG antibody (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.) in conjunction with a goat anti-rabbit IgG conjugated with horseradish peroxidase (Santa Cruz Biotechnology), as described previously [19] , and visualized using ECL ® reagent (Amersham Biosciences).
As another approach to resolve the constellation of MTF-1 flag spots, two-dimensional electrophoresis with samples prepared in SDS and a pH gradient of 4-7 was employed. SDS affects • C at 80 000 g for 30 min. The extracts, diluted by 2-fold with whole cell extraction buffer without KCl, were then incubated with anti-FLAG M2-agarose affinity resin (Sigma) at 4
• C for 2 h, and the resin was collected by centrifugation. After three washes with wash buffer [20 mM Hepes, pH 7.9, 150 mM KCl, 30 µM ZnSO 4 , 20 mM NaF, 1 mM Na 3 VO 4 and 1 × protease inhibitor cocktail without EDTA (Roche)], MTF-1 flag was eluted from the beads by heating at 95
• C for 10 min in SDS sample buffer without 2-mercaptoethanol. The supernatant was collected, adjusted to 5 % 2-mercaptoethanol and heated at 95
• C for another 5 min. These samples were then separated by two-dimensional electrophoresis (Kendrick Labs), subjected to Western blotting and detected using an anti-FLAG antibody (Santa Cruz Biotechnology) as described above, except that IEF was performed using 1 % (pH 4-6) ampholines (LKBPharmacia) and 1 % ( pH 4-8) ampholines (Gallard-Schlesinger Industries, Garden City, NY, U.S.A.).
In vitro phosphorylation of MTF-1 flag
Recombinant mouse MTF-1 flag (approx. 100 ng) was incubated at 30
• C for 60 min (i) with JNKs (20 ng for JNK1 or 100 ng for JNK2; Upstate Cell Signaling Solutions, Lake Placid, NY, U.S.A.) in 50 µl of JNK buffer (20 mM Mops, pH 7.2, 25 mM β-glycerol phosphate, 5 mM EGTA, 1 mM Na 3 VO 4 , 1 mM dithiothreitol and 15 mM MgCl 2 , supplemented with 100 µM ATP/10 µCi of [γ -32 P]ATP) or (ii) with CKII (50 units; Calbiochem) in 50 µl of CKII buffer {20 mM Tris/HCl (pH 7.5), 50 mM KCl and 10 mM MgCl 2 , supplemented with 200 µM ATP/10 µCi of [γ -32 P]ATP} or (iii) with PKC (70 ng; Calbiochem) in 50 µl of PKC buffer (20 mM Tris/HCl, pH 7.5, 10 mM MgCl 2 , 0.5 mM CaCl 2 , 0.3 mg/ml phosphatidylserine, 0.03 mg/ml diacylglycerol and 0.3 % Triton X-100, supplemented with 15 µM ATP/5 µCi of [γ -32 P]ATP). Reactions were then boiled for 5 min in SDS sample buffer and subjected to SDS/PAGE. The phosphorylated MTF-1 flag was detected by autoradiography at − 70
• C with intensifying screens.
ChIP (chromatin immunoprecipitation)
ChIP assays were performed as described previously [15] with modifications. Cells were cultured for 1 h in basal medium with or without kinase inhibitors and then for 1 h in the same medium with or without ZnSO 4 (100 µM) or CdCl 2 (20 µM) before fixation in 1 % formaldehyde. Cross-linking was stopped by the addition of glycine to a final concentration of 0.125 M. After homogenization of the cells as described previously [16] , the nuclei were lysed in sonication buffer [15] , the chromatin was sonicated to an average length of 600-1000 bp and clarified by centrifugation at 12 000 g for 10 min at 4
• C. The chromatin was diluted by 10-fold in ChIP dilution buffer [29] , precleared with Protein A-Sepharose (Sigma) and immunoprecipitated with anti-FLAG M2-agarose affinity gel (Sigma) or an anti-MTF-1 antibody [19] or an anti-RNA polymerase II antibody (Santa Cruz Biotechnology) plus Protein A-Sepharose. The beads were washed, the immunocomplexes were eluted and the cross-links were reversed as described previously [29] . The DNA was phenol/chloroform-extracted, reconstituted in TE buffer (10 mM Tris/1 mM EDTA, pH 8.0) and analysed by PCR using primers that span − 230 to + 123 bp (relative to the transcription start site) of the mouse MT-I gene. PCR products (31 cycles) were separated by electrophoresis on TAE-agarose gels (composition of TAE: 40 mM Tris/40 mM acetate/1 mM EDTA, pH 8.3) and then stained with SYBR Green (Sigma), quantified using the ChemiImager System (Alpha Innotech, San Leandro, CA, U.S.A.) and normalized to input products. For initial experiments, input and immunoprecipitated DNA samples were analysed at various cycles (27-33 cycles) to ensure that the PCR products were obtained in the linear range of amplification.
RESULTS
Effects of inhibitors of PKC, CKII and JNK on metal-induced MT-I and ZnT-1 gene expression
To examine the roles of signalling cascades in the metal-induced gene expression regulated by MTF-1, cell-permeant inhibitors of various kinases were used to treat Hepa and MEF cells before metal treatment, and MT-I and ZnT-1 mRNA levels in these cells were determined by Northern blotting. The MEF cells used in the present study were MTF-KO MEFs, stably transfected with an expression vector for a full-length mouse MTF-1 tagged with a FLAG epitope (MTF-1 flag ), which facilitates the detection and purification of the protein in subsequent studies. Similar to the native protein, MTF-1 flag translocates into the nucleus and shows increased in vitro DNA binding after exposure of the cells to zinc, forms a stable complex with the MT-I promoter chromatin in vivo in response to zinc and cadmium, and fully restores metal-induced MT-I gene expression [15] .
DRB is an inhibitor of CKII. Pretreatment of Hepa cells and MEF cells expressing MTF-1 flag (line 42) with DRB severely attenuated the metal-induced expression of both MT-I and ZnT-1 genes (Figures 2A, 2B and 2D ). Both MT-I and ZnT-1 mRNA levels were greatly reduced in cells treated with DRB plus metals compared with cells treated with metals only. Similarly, pretreatment of Hepa and MEF cells (line 42) with dicoumarol, an inhibitor of JNK signalling, significantly attenuated metalinduced MT-I and ZnT-1 gene expression (Figures 2A, 2B and  2D) . These results are consistent with roles for CKII and JNK in metal regulation of gene expression, as suggested previously [25] [26] [27] .
H7 and staurosporine are broad-spectrum inhibitors of protein kinases including PKC, whereas BIM I (bisindolylmaleimide I) is a selective inhibitor of PKC. To our surprise, these inhibitors exerted differential effects on basal as well as metal-induced MT-I and ZnT-1 gene expression. In mouse Hepa cells, H7 had no effect on the metal-induction of the MT-I gene, but completely abolished ZnT-1 induction even when present at low concentrations (Figure 2C) . In contrast, H7 blocked both MT-I and ZnT-1 induction in MEF cells (line 42; Figures 2D and 2E) . BIM I caused a large increase in the basal levels of ZnT-1 mRNA in Hepa cells, but the magnitude of this effect on the basal levels of MT-I mRNA was variable. The metal-induced MT-I and ZnT-1 mRNA levels in BIM I-and metal-treated Hepa cells were similar to those in cells treated with metals only (Figures 2A and 2B ). Similarly, staurosporine had little effect on the metal induction of the MT-I gene, and had variable effects on ZnT-1 gene expression in Hepa cells (Figures 2A and 2B ). In contrast, BIM I and staurosporine severely attenuated metal induction of the MT-I gene in MEF cells, but had little effect on the basal levels of MT-I mRNA ( Figure 2D) . These results suggest cell-type-and gene-specific roles for PKC in the metal regulation of gene expression.
MTF-1 is phosphorylated in vivo, but the extent of incorporation of phosphate is not altered after metal treatment
MTF-1 is phosphorylated in vivo in transfected COS and HEK-293 cells [25] [26] [27] . In a recent study, a 2-4-fold increase in MTF-1 phosphorylation was detected after 20 min of zinc treatment [26] . However, MTF-1 is overexpressed significantly in transfected cells, which may affect these results. In other studies, phosphorylated MTF-1 increased in the nucleus after metal treatment [25, 27] , consistent with metal-induced MTF-1 nuclear translocation [19, 20] . In the present study, we examined the phosphorylation state of native MTF-1 in response to zinc and cadmium, and we focused on the time period of induction of gene transcription by metals (within 1 h). Mouse Hepa cells were incubated in phosphate-deficient medium containing [ 32 P]P i and treated for 30 min with zinc or cadmium. MTF-1 was immunoprecipitated, separated on a denaturing polyacrylamide gel and detected by autoradiography. Equal loading of each lane was confirmed by silver staining of the slab gel (results not shown). A radioactive protein with an apparent molecular mass of 100 kDa was detected in control as well as metal-treated cells (Figure 3 ). This protein co-migrated with immunoreactive MTF-1 and was absent from the control reactions that were immunoprecipitated with preabsorbed antiserum (Figure 3) . These results confirmed that MTF-1 is phosphorylated in vivo. Although this experiment may not have detected small changes in MTF-1 phosphorylation, 
MTF-1 flag is highly modified in vivo, but metal treatment does not cause a significant change in its modification pattern
To determine the extent of MTF-1 modification and to assess the effects of metal treatment on the modification pattern of MTF-1, we employed two-dimensional electrophoresis coupled with Western blotting. To facilitate detection of the MTF-1 protein, two stably transfected MEF cell lines expressing MTF-1 flag (lines 9 and 42) were examined [15] .
In initial experiments, recombinant MTF-1 flag isolated from E. coli by anti-FLAG affinity chromatography and whole cell lysates from MTF-KO cells and MTF-1 flag -expressing cells (line 42) before or after metal treatment were prepared in urea and subjected to two-dimensional electrophoresis (pH 3.5-10). The resulting SDS slab gel was stained with Coomassie Blue or transblotted on to PVDF membranes and Western blotted using an anti-FLAG antibody. A constellation of 6-8 spots with pI values ranging from 4.8 to 5.7 was detected in MTF-1 flag -expressing cells (line 42; Figure 4A ). This constellation represented MTF-1 flag , since it was absent from the cell lysate from MTF-KO cells that lack endogenous MTF-1 ( Figure 4A ). Recombinant mouse MTF-1 flag isolated from E. coli migrated as a single spot with a pI of approx. 5.7 ( Figure 4A ). These results indicate that MTF-1 flag expressed in mammalian cells is highly modified. The fact that these modifications reduced the pI of the protein is consistent with MTF-1 being phosphorylated. However, the electrophoretic migration pattern of MTF-1 flag appeared to be essentially the same in untreated and metal-treated cells ( Figure 4A ). Thus metal treatment did not cause a significant change in the modification pattern of MTF-1, although we cannot exclude the possibility of subtle changes that are not revealed using this method.
To extend the above observations and to resolve better the constellation of MTF-1, MTF-1 flag was isolated by anti-FLAG M2-agarose affinity chromatography from whole cell extracts prepared from MTF-1 flag -expressing cells (lines 9 and 42) before or after a 1 h treatment with metals and then dissolved in SDS sample buffer and subjected to two-dimensional electrophoresisWestern blotting using a narrower pH gradient (pH 4-7). A constellation of MTF-1 flag with pI values ranging from 5.1 to 5.6 was detected in both cell lines ( Figure 4B ), indicating that MTF-1 flag in both cell lines is highly modified. However, consistent with the above observations, the electrophoretic migration pattern of MTF-1 flag appeared to be essentially the same in untreated and metal-treated cells in both cell lines ( Figure 4B ), confirming that metal treatment did not cause a significant change in the modification pattern of MTF-1.
MTF-1 can serve as an in vitro substrate for CKII, PKC and JNK, but inhibition of these protein kinases does not cause a significant change in its modification pattern in vivo
To determine whether MTF-1 flag can serve as a substrate for CKII, PKC and JNK, in vitro assays were performed using purified kinases and recombinant mouse MTF-1 flag isolated from E. coli by anti-FLAG M2-agarose affinity chromatography.
Incubation of recombinant MTF-1 flag with CKII (a promiscuous kinase that is constitutively active [30] ), PKC (affinity-purified from rat brain, contains predominantly the conventional PKC isoforms α, β 1 , β 2 and γ ) or JNKs (JNK1 or JNK2, the two main isoforms of JNKs that are ubiquitously expressed [31] ) in the presence of [γ -
32 P]ATP resulted in a radiolabelled product with an apparent molecular mass of 100 kDa, which was not present in control reactions in which no MTF-1 flag was added ( Figure 5 ). Incorporation of 32 P into MTF-1 flag was kinase-dependent, since no radiolabelled MTF-1 flag was detected when the kinases were omitted from the reaction (results not shown). Although the extent of incorporation of 32 P into MTF-1 flag by PKC was very low when compared with that by CKII or JNKs under comparable reaction conditions, these results demonstrated that MTF-1 flag can serve as a substrate for each of these kinases in vitro.
As another approach for revealing the roles of PKC, CKII and JNK in MTF-1 modification, we investigated whether inhibition of these kinases affects the modification pattern of MTF-1, using two-dimensional electrophoresis-Western blotting. MTF-1 flag was affinity-purified from MTF-1 flag -expressing cells (line 42) [15] treated with kinase inhibitors for 4 h. The results demonstrated that the modification pattern of MTF-1 flag from DRB-treated cells was essentially indistinguishable from that of control cells, whereas treatment with staurosporine or dicoumarol appeared to reduce slightly, but clearly did not eliminate, the complex modification pattern of MTF-1 flag (Figure 6 ). Overall, inhibition of these protein kinases had little effect on the modification pattern of MTF-1 flag . These results suggest that the protein kinases examined are not solely responsible for maintaining the complex modification pattern of MTF-1 and/or that these modifications are relatively stable and do not turn over within the 4 h inhibition period.
Inhibitors of PKC, CKII and JNK have no effect on the metal-dependent recruitment of MTF-1 flag to the endogenous MT-I promoter
A ChIP assay was employed to assess whether PKC, CKII and JNK exert their effects on metal-induced MT-I gene expression by modulating metal-dependent recruitment of MTF-1 to the MT-I promoter in vivo. Soluble cross-linked chromatin was prepared from Hepa cells or MTF-1 flag -expressing cells (line 42) that have been pretreated with kinase inhibitors before metal treatment. The chromatin was immunoprecipitated using anti-FLAG M2-agarose affinity resin, anti-MTF-1 antibody plus Protein A-Sepharose or Sepharose beads alone. The amount of MT-I proximal promoter DNA present in the precipitates was quantified by PCR and normalized to input DNA. Consistent with our previous results [15] , the amount of MTF-1 bound to the chromosomal MT-I promoter was rapidly (1 h) and significantly increased (by approx. 5-fold in Hepa cells and approx. 2.5-fold in line 42) after exposure of the cells to zinc or cadmium (Figure 7) . However, the increased binding of MTF-1 to the MT-I promoter in response to metals was not attenuated by pretreatment with any of the kinase inhibitors examined, including DRB and dicoumarol in either MEF cells (line 42; Figure 7A ) or Hepa cells ( Figure 7B ). Interestingly, in Hepa cells, the basal chromosome-binding activity of MTF-1 was apparently increased (2.1-2.7-fold) in cells that were pretreated with kinase inhibitors alone compared with the untreated control. However, the metal-induced recruitment of MTF-1 to the promoter was still measurable ( Figure 7A ). Thus CKII, PKC and JNK exert their role in metal-induced MT-I gene expression at a step subsequent to the metal-induced recruitment of MTF-1 to the MT-I promoter.
Similarly, none of these kinase inhibitors reduced the amount of RNA Pol II (RNA polymerase II) bound to the MT-I promoter ( Figure 7 ). In cells cultured in basal medium, there was a significant amount of RNA Pol II bound to the MT-I promoter (Figure 7) . This reflects the fact that this gene is actively transcribed even in the absence of exogenous metals, probably due to the presence of zinc in the medium. In the absence of kinase inhibitors, the amount of RNA Pol II bound to the MT-I promoter was evidently increased (by approx. 2-fold) after exposure of the cells to metals. In the presence of kinase inhibitors, the basal levels of RNA Pol II bound to the promoter were slightly increased and did not change significantly after metal treatment (Figure 7 ). Thus inhibition of metal-induced MT-I gene expression does not result from a loss of RNA Pol II at the promoter.
DISCUSSION
It has been shown previously that protein kinase signalling cascades play a role in metal-induced MT-I gene expression [24] [25] [26] [27] , and this role was suggested to involve changes in the phosphorylation of MTF-1 [24] [25] [26] [27] . Our results extend our understanding of the involvement of protein kinase signalling in metal-induced gene expression, but suggest that changes in MTF-1 phosphorylation may not play a paramount role in this regulation, at least during the initial phase of gene activation. A novel finding that inhibitors of PKC exert gene-and cell-type-specific effects on the expression of these two genes is consistent with the suggestion that MTF-1 is not the direct target(s) of signalling in these cells. Instead, a cofactor or a group of cofactors specific to each gene may be the real targets of PKC modification. The finding of cell-type-specific effects of inhibitors of PKC on metal regulation of these genes is surprising, but supports the concept that this regulation may involve multiple kinase cascades and genespecific co-activators that may be uniquely represented in each of these cell types. The involvement of multiple signal transduction cascades, possible cross-talk between them, and their remarkable interdependent effects on the metal-dependent regulation of these genes are consistent with this concept. It should also be kept in mind that the inhibitors used in these studies are by no means specific to only one kinase, and unidentified kinases may also be inhibited by these compounds. Furthermore, there are multiple isoenzymes of PKC, which further complicates the interpretation of these results.
Consistent with the idea that MTF-1 may not be the real target of these signalling events, our results demonstrate that endogenous MTF-1 is constitutively phosphorylated in vivo in Hepa cells, and provide evidence for the first time that metal treatment does not cause a significant change in the extensive modification pattern of MTF-1. This result contrasts with a previously reported increase in the incorporation of phosphate into MTF-1 after metal treatment [26] . The reason for this difference is not clear. However, LaRochelle et al. [26] analysed the phosphorylation of the MTF-1 overexpressed in transiently transfected COS cells, whereas we examined the phosphorylation of the endogenous native MTF-1 in Hepa cells. Also, our experiment would not reveal small changes (< 2-fold) in MTF-1 phosphorylation.
For direct phosphorylation of MTF-1 to play a role in the metalloregulatory functions of MTF-1, the responsible kinase(s) would be predicted to act quickly in response to metals, which would require the critical phosphate group(s) to be labile. The subtle changes in the modification pattern of MTF-1 after a prolonged inhibition of PKC, CKII and JNK, which attenuates metal induction of MTF-1 target genes, suggest that most of the modifications of MTF-1 are quite stable. Although previous findings that inhibition of these protein kinases impaired the metal-induced expression of MREd-driven reporter genes [25] [26] [27] suggest that MTF-1 is involved in the regulation of metal-induced gene expression by these kinases, the differential effects of protein kinase inhibitors on metal-induced expression of the MT-I and ZnT-1 genes, both MTF-1 target genes, argues against a common mechanism of signalling cascades directly modulating MTF-1 activity. Given that our results also demonstrated that kinase inhibitors did not block the metal-induced formation of the MTF-1-chromatin complex, we suggest that phosphorylation events may indirectly modulate the metalloregulatory functions of MTF-1, perhaps by acting on cofactors that interact with MTF-1. The idea that modifications of cofactors can alter their interactions with transcription factors and/or their activity has been well documented. Phosphorylation of NDD1p, a co-activator of the forkhead transcription factor Fkh2p, is required for its interaction with and normal transcriptional regulation by the transcription factor [32] . C/EBPs (CCAAT/enhancer-binding proteins) transactivate gene expression by recruiting the co-activators CBP (CREB-binding protein, where CREB stands for cAMP-responseelement-binding protein) and p300, which, in turn, promotes transcription by acetylating histones and recruiting general transcription factors. Recruitment of CBP and p300 by C/EBP triggers the phosphorylation of CBP and p300, which is required for their co-activator functions [33, 34] .
To date, no co-activators have been identified to interact with MTF-1. Upstream stimulatory factors have been shown to participate in cadmium-induced MT-I gene expression [35] . However, a direct interaction of upstream stimulatory factor 1 with MTF-1 has not been observed. Although a role for a metal-sensing inhibitor of MTF-1 has been suggested in metal regulation of MT-I gene expression [36] , the isolation of such an inhibitor has not been reported. If protein kinases act on this inhibitor to modulate metal-induced gene expression, it is unlikely that this inhibitor is involved in the chromatin-binding activity of MTF-1. The increased basal expression of the MT-I and ZnT-1 genes in BIM I-or staurosporine-treated Hepa cells suggest that dephosphorylation events possibly facilitate the release of this inhibitor from the chromatin-bound MTF-1, allowing the transcription factor to recruit a co-activator and/or the general transcription machinery. In addition to potentially acting on putative MTF-1-interacting cofactors, some of these kinase inhibitors may affect the general transcription machinery. DRB is known to inhibit kinases that phosphorylate the C-terminal domain of the largest subunit of RNA Pol II and efficiently blocks RNA Pol II in the early elongation stage [37, 38] . Therefore the effects of DRB treatment on metal-induced gene expression may reflect inhibition of transcriptional elongation.
Although we consider it unlikely, our results cannot formally exclude the possibility that metal ions may cause a subtle change in the phosphorylation state of MTF-1 or a change in a subpopulation of MTF-1 molecules, which directly affect its metalloregulatory functions. Interestingly, there is a highly conserved PKC consensus site (S/T-X-R/K) and a JNK consensus site (S/T-P) within a conserved cysteine-rich region near the C-terminus of MTF-1. This cysteine-rich region has been suggested to play a role in the metal-regulated transactivation of gene expression by MTF-1 [21] . It is possible that metal-activated signal transduction cascades may specifically affect the ability of this region to interact with metals and/or other transcription factors or co-activators.
Another point worth noting is that most of the MTF-1 resides in the cytoplasm in resting cells, but moves into the nucleus after exposure to zinc [19, 20] . The similar two-dimensional migration pattern of MTF-1 in both untreated and zinc-treated cells suggests that cytoplasmic and nuclear MTF-1s share similar modifications. This, in turn, suggests that the majority of phosphorylation events occur in the cytoplasm and have no effect on zinc-induced nuclear translocation of MTF-1.
It has been proposed that cadmium utilizes a distinct mechanism, relative to zinc, to induce gene expression. However, so far, studies have not been able to differentiate these two metals in terms of gene induction. The findings that the modification pattern of MTF-1 appears to be the same after zinc or cadmium treatment, and that kinase inhibitors block MT-I and ZnT-1 gene induction by both zinc and cadmium to the same extent, all point to a common mechanism utilized by these two metals. As suggested previously [23, 36] , cadmium may cause redistribution of a small fraction of cellular zinc, probably from the zinc pool bound by MT, which is sufficient to activate nuclear MTF-1 to form a stable complex with the promoter and then activate gene transcription. This, in turn, suggests that a subpopulation of MTF-1 is sufficient to form a stable chromatin complex and to carry out its metalloregulatory functions. However, inhibition of PKC, CKII or JNK does not affect cadmium-induced MTF-1 binding to the MT-I promoter chromatin.
In summary, our studies confirm the involvement of PKC, CKII and JNK signalling in metal-induced MT-I and ZnT-1 gene expression. However, the effects of PKC signalling are gene-and cell-type-specific. We also demonstrate that, although MTF-1 is phosphorylated in vivo and can serve as a substrate for these kinases in vitro, neither metal treatment nor inhibition of these kinases changes the MTF-1 modification pattern significantly. Furthermore, all three kinases seem to act subsequent to the metal-dependent recruitment of MTF-1 to the MT-I promoter. Taken together, our results suggest that inhibitors of PKC, CKII and JNK modulate metal-induced gene expression by acting on putative MTF-1-interacting cofactors.
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